About Victoria Ramé

This author Victoria Ramé has created 4 entries.

Meet Humana Biosciences at Biofit !

biofit2018

Humana Biosciences is attending to the 7th edition of Biofit the 4th and 5th December 2018 in Lille, France. Our team will be glad to meet you and discuss about your R&D projects during this event. What is BioFIT ? With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from

The value of human tissue studies in translational research

goinpharma

Our CEO, Dr. Stefano Palea, recently wrote an expert insight note for GoINPharma (to read all of it, click on the link) about the value of human tissue studies in translational research. In this article, he shares his vision and explains what is – sometimes – going wrong in the preclinical studies process, and how to improve it with human tissue. For instance, he explains the perks of using human tissue to study drug candidate’s efficacy and

Humana Biosciences to attend the AFSSI Connexion 2018

AFSSI

We are pleased to announce our presence at the 6th edition of the AFSSI Connexions, the annual meeting of preclinical research, on 3rd July in Marseille, France. This meeting is the French annual marketplace for the life sciences R&D that gather several preclinical companies and institutions. We will attend the business convention between 9AM and 6PM. Should you like to join us at the AFSSI Connexions, please don’t hesitate to let us know.  

Partnership with Dr. Goffin

Dr. Vincent GOFFIN is the Head of the “PRL/GH Pathophysiology: Translational Approaches” laboratory, which is part of INSERM Unit 1151/Institut Necker Enfants Malades (INEM) located on the Necker Campus at Paris (France). This laboratory aims to identify, understand, predict and target cellular and molecular mechanisms responsible for the initiation, progression and/or resistance to treatment of benign and malignant tumors affecting the breast and the prostate. This lab is specialized in translational studies that over the years have included the use and analyses